Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab

IMPORTANCE: Prurigo nodularis (PN) is a debilitating skin disease characterized by intense pruritus and hyperkeratotic skin nodules. Nemolizumab, a monoclonal antibody targeting interleukin 31 receptor α, is a promising novel therapy for the treatment of moderate to severe PN. The biological mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Junwen, Liao, Viviane, Parthasarathy, Varsha, Cornman, Hannah L., Kambala, Anusha, Kwatra, Madan M., Ständer, Sonja, Piketty, Christophe, Chaskar, Prasad, Krishnaswamy, Jayendra Kumar, Julia, Valerie, Kwatra, Shawn G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413221/
https://www.ncbi.nlm.nih.gov/pubmed/37556125
http://dx.doi.org/10.1001/jamadermatol.2023.2609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413221/
https://www.ncbi.nlm.nih.gov/pubmed/37556125
http://dx.doi.org/10.1001/jamadermatol.2023.2609

Ejemplares similares